| Financial Year |
March 31 2023 |
| Monetary Funds |
950,060,348.31 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
52,170,746.59 |
| Advances to Suppliers |
12,878,367.67 |
| Other Receivables |
45,833,913.12 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
356,150,966.14 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
66,378,900.43 |
| Total Current Assets |
1,584,297,196.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,941,996,683.39 |
| Investment Properties |
661,858,584.39 |
| Fixed Assetes |
5,300,784,522.41 |
| Under-construction Projects |
962,220.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
33,995,142.21 |
| R&D expenses |
-- |
| Goodwill |
1,124,077.08 |
| Long-Term Deferred and Prepaid Expenses |
37,250,631.83 |
| Deferred Income Tax Assets |
43,616,962.40 |
| Other Non-Current Assets |
160,263,640.93 |
| Sub-Total of Non-Current Assets |
8,195,962,627.01 |
| Total Assets |
9,780,259,823.80 |
| Short-Term Loans |
349,990,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
37,235,300.26 |
| Accounts Received In Advance |
6,107,299.29 |
| Employee Compensation Payable |
31,137,873.37 |
| Taxes Payable |
44,747,044.61 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
192,127,566.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
466,206,736.87 |
| Other Current Liabilities |
253,780,915.71 |
| Sub-Total of Current Liabilities |
1,386,420,732.79 |
| Long-term Loans |
1,905,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
617,871,239.36 |
| Special Payable |
-- |
| Estimatied Liabilities |
7,231,396.45 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,564,643,513.06 |
| Total Liabilities |
3,951,064,245.85 |
| Paid-In Capital(Or Share Stock) |
1,125,632,068.00 |
| Capital Surplus |
467,645,116.19 |
| Surplus Reserve |
590,223,889.32 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,716,035,448.90 |
| Minority Stockholder's Interest |
-71,212,460.22 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,900,408,038.17 |
| Owner's Equity（Stockholder's Equity） |
5,829,195,577.95 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,780,259,823.80 |
